Pearl River Capital’s MacroGenics MGNX Stock Holding History

Pearl River Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,116	Closed	-$74K	–	407
2019 Q1	$74K	Buy	+4,116	New	+$71.1K	0.18%	206

Other funds holding MGNX

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pearl River Capital's MGNX Position: Q2 2019 in Review

Pearl River Capital sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 4,116 shares — an estimated $74K sold.

Pearl River Capital first reported a position in MGNX in Q1 2019 and held it in 1 quarter. The position peaked at $74K in Q1 2019. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

Pearl River Capital reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
Pearl River Capital sold 4,116 MacroGenics shares in Q2 2019, an estimated $74K.
Pearl River Capital first reported a position in MacroGenics in Q1 2019 and held it in 1 quarter.
Pearl River Capital's MacroGenics position peaked at $74K in Q1 2019.
130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Pearl River Capital's 13F filing for Q2 2019, filed 12 Aug 2019.